(VIANEWS) – Catalyst Pharmaceuticals (CPRX), Agree Realty Corporation (ADC), CubeSmart (CUBE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Catalyst Pharmaceuticals (CPRX)
73.5% sales growth and 28.55% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.71.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 21.56. Meaning, the purchaser of the share is investing $21.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.55%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 59.2%, now sitting on 191.76M for the twelve trailing months.
Sales Growth
Catalyst Pharmaceuticals’s sales growth is 51.6% for the current quarter and 73.5% for the next.
2. Agree Realty Corporation (ADC)
18.7% sales growth and 3.8% return on equity
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.83.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 40.87. Meaning, the purchaser of the share is investing $40.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.8%.
3. CubeSmart (CUBE)
10% sales growth and 9.86% return on equity
CubeSmart is a self-administered and self-managed real estate investment trust. The Company's self-storage properties are designed to offer affordable, easily accessible and secure storage space for residential and commercial customers. According to the 2020 Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.
Earnings Per Share
As for profitability, CubeSmart has a trailing twelve months EPS of $1.14.
PE Ratio
CubeSmart has a trailing twelve months price to earnings ratio of 39.75. Meaning, the purchaser of the share is investing $39.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.86%.
Yearly Top and Bottom Value
CubeSmart’s stock is valued at $45.32 at 15:22 EST, way below its 52-week high of $54.95 and way above its 52-week low of $36.82.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.9%, now sitting on 973.04M for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 29, 2022, the estimated forward annual dividend rate is 1.96 and the estimated forward annual dividend yield is 4.32%.
Sales Growth
CubeSmart’s sales growth is 17.4% for the current quarter and 10% for the next.
Previous days news about CubeSmart(CUBE)
- Cubesmart (cube) Q4 FFO and revenues beat estimates. According to Zacks on Friday, 24 February, "While CubeSmart has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
4. Stantec (STN)
8.3% sales growth and 9.03% return on equity
Stantec Inc. provides professional consulting services in the area of infrastructure and facilities in Canada, the United States, and internationally. The company provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. It also offers water, transportation, and public works; transportation planning and traffic engineering; and resource assessment, mine development, reclamation, hydrology, and geotechnical and infrastructure engineering services, as well as urban planning, traffic assessments and optimization, environmental impact assessments, and public consultation services. In addition, the company provides structural, mechanical, electrical, plumbing, and hydraulics engineering services. It serves urban regeneration, infrastructure, education, public and private sector, tourism and leisure, and waste and water sectors, as well as office and commercial, residential, and retail and town centers. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.
Earnings Per Share
As for profitability, Stantec has a trailing twelve months EPS of $1.24.
PE Ratio
Stantec has a trailing twelve months price to earnings ratio of 46.12. Meaning, the purchaser of the share is investing $46.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.03%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 28, 2022, the estimated forward annual dividend rate is 0.54 and the estimated forward annual dividend yield is 1.02%.
Previous days news about Stantec(STN)
- Stantec (stn) Q4 earnings surpass estimates. According to Zacks on Thursday, 23 February, "While Stantec has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
